A limited amount of H1N1 vaccine and Seasonal Flu vaccine is available in the Board of Health office during Nursing Clinic Hours. No appointment is necessary. While supplies last:
Monday through Friday 8:30 - 9:30 am and 4:00 - 4:45 pm and Tuesday evenings from 6-8 PM

The vaccine is free. If you have health insurance, please bring your health insurance cards with you.

To listen to this message, please call the Flu Clinic Hotline Number: 508-532-5478

The Town of Framingham Board of Health DID NOT DISPENSE any H1N1 vaccine AT ANY TIME currently under a voluntary recall: the pediatric prefilled syringes for ages 6-35 months. If you have any questions about the recall, visit the CDC website at www.cdc.gov

Thimerosal

• See www.cdc.gov for information about thimerosal and vaccine safety 
• There is no convincing scientific evidence of harm caused by the minute doses of thimerosal in vaccines except for minor effects like swelling and redness at the injection site due to sensitivity to thimerosal. 
• Most importantly, since 1999, newly formulated thimerosal-free vaccines have been licensed. With the newly formulated vaccines, the maximum cumulative exposure during the first six months of life will now be less than three micrograms of mercury. No children are receiving toxic levels of mercury from vaccines. 
• Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials (vials containing more than one dose) of some vaccines to prevent the growth of microorganisms, such as bacteria and fungi, which may contaminate them. 
• In vaccines, preservatives are used to prevent the growth of bacteria and fungi in the event that they get into the vaccine. This may occur when a syringe needle enters a vial as a vaccine is being prepared for administration. Contamination by germs in a vaccine could cause serious illness or death. In some vaccines, preservatives are added during the manufacturing process to prevent microbial growth. 
• FDA licensed (approved) several formulations of the 2009 H1N1 influenza vaccines, including multi-dose vials and single-dose units. Multi-dose vials contain thimerosal as a preservative to prevent potential contamination after the vial is opened 
• Some vaccine manufacturers are producing 2009 H1N1 influenza vaccines in single-dose units, which do not require the use of thimerosal as a preservative. In addition, the live-attenuated version of the vaccine, which is administered intranasally (through the nose), is produced in single-units and does not contain thimerosal.

CDC has received reports of fraudulent emails (phishing) referencing a CDC sponsored State Vaccination Program for H1N1. The messages request that users create a personal H1N1 (swine flu) Vaccination Profile on the CDC.gov web site.
The Town of Framingham Board of Health is not soliciting personal H1N1 personal profiles over th internet!
An example of the phishing email is below: